Tags: Drug.

PF-03654746 is a potent and selective histamine H3 receptor antagonist developed by Pfizer and currently undergoing clinical trials for the treatment of ADHD Tourette syndrome as well as potential anti-allergy applications.

PF-03654746_structure.png
IUPAC name
(1R3R)-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]cyclobutane-1-carboxamide
PubChem
16119086

Loading...

This page contains content from the copyrighted Wikipedia article "PF-03654746"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.